Efficacy and safety of oral orforglipron in Japanese participants…
Oral orforglipron produced substantially more weight loss than placebo over 72 weeks in Japanese participants, offering a potential new medication option for obesity.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Development and multicenter validation of a cfDNA methylation-based…
A blood-based test showed promise for detecting esophageal cancer non-invasively, though early-stage detection rates need improvement before clinical use.
Early cancer detection or preventionMachine Learning-Enhanced Terahertz-Colorimetric Dual-Mode Metadevice…
A machine-learning microRNA blood test detected all early pancreatic cancers in a small study, though larger validation is needed to confirm its real-world value.
Standard additionComparative survival and time toxicity outcomes of CAR-T versus…
CAR-T therapy extended progression-free survival compared to bispecific antibodies in blood cancers, though it required more healthcare contact in the first year.
Standard additionReal-World Treatment Patterns and Outcomes of Zanubrutinib and…
Zanubrutinib kept patients on treatment longer than acalabrutinib in real-world blood cancer care, with similar survival outcomes between the two drugs.